Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia

NCT07228273 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
102
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

OHSU Knight Cancer Institute

Collaborators